Pemphigus Research Foundation

Pemphigus Research Foundation
Name	Pemphigus Research Foundation
Founded	1987
Founder	Barbara J. Roux
Type	Nonprofit
Focus	Autoimmune blistering diseases
Headquarters	Austin, Texas
Key people	Barbara J. Roux; James N. C. K. Chan; Dermatology Research Institute

Pemphigus Research Foundation is a nonprofit organization dedicated to accelerating research, improving patient care, and raising awareness for autoimmune blistering diseases such as pemphigus vulgaris and pemphigus foliaceus. The Foundation supports basic science, clinical trials, patient education, and advocacy through grantmaking, partnerships, and outreach to clinicians, researchers, and patient communities. Its activities intersect with academic centers, pharmaceutical companies, regulatory agencies, and patient advocacy networks.

History

The Foundation was established in 1987 by Barbara J. Roux with early collaborations involving institutions like University of Texas, St. John's Hospital, Massachusetts General Hospital, Mayo Clinic, and Johns Hopkins Hospital. In its formative years it connected investigators from Harvard Medical School, Stanford University, University of Pennsylvania, Columbia University, and University of California, San Francisco. Throughout the 1990s and 2000s the organization convened symposia that included speakers from National Institutes of Health, Food and Drug Administration, European Academy of Dermatology and Venereology, American Academy of Dermatology, and British Association of Dermatologists. The Foundation's historical milestones feature partnerships with research groups at Yale University, Duke University School of Medicine, University of Chicago, Northwestern University, and University of Michigan. Its archives document interactions with philanthropic entities such as Howard Hughes Medical Institute, Bill & Melinda Gates Foundation, W. M. Keck Foundation, and patient registries modeled on programs from National Psoriasis Foundation and Cystic Fibrosis Foundation.

Mission and Programs

The Foundation's mission emphasizes translational research and patient support, aligning with clinical networks like International Pemphigus and Pemphigoid Foundation, European Network for Rare Skin Diseases, American Skin Association, Dermatology Foundation, and Pediatric Dermatology Research Alliance. Programmatic areas include funding cohorts and registries in collaboration with ClinicalTrials.gov, multicenter trials with sites connected to Vanderbilt University Medical Center, Cleveland Clinic, Weill Cornell Medicine, Oregon Health & Science University, and biomarker discovery projects linked to Broad Institute, Sanger Institute, Karolinska Institutet, and Wellcome Trust. Educational initiatives have partnered with professional meetings such as Society for Investigative Dermatology, International League of Dermatological Societies, European Dermatology Forum, and American College of Rheumatology.

Research and Grants

Grant programs support investigators at institutions including Imperial College London, University of Toronto, McGill University, Monash University, Seoul National University, Peking University Health Science Center, and National University of Singapore. Research topics funded span autoantibody profiling with teams at Cold Spring Harbor Laboratory, complement biology with researchers at Max Planck Institute, and B cell targeted therapies evaluated alongside pharmaceutical partners such as Rituximab trials conducted at centers like University College London Hospitals. Grants have extended to basic scientists affiliated with Korean Research Institute of Bioscience and Biotechnology, Instituto Nacional de Salud Carlos III, Fundación Jiménez Díaz, and translational groups working with regulatory stakeholders such as European Medicines Agency and Centers for Medicare & Medicaid Services on endpoints and reimbursement frameworks. The Foundation organizes grant review panels drawing reviewers from American Society of Clinical Oncology, National Academies of Sciences, Engineering, and Medicine, and editorial boards of journals like The New England Journal of Medicine, The Lancet, JAMA Dermatology, Nature Medicine, and Science Translational Medicine.

Patient Services and Advocacy

Patient-facing services include helplines, educational webinars, and peer support modeled on programs by American Cancer Society, Alzheimer's Association, American Diabetes Association, Multiple Sclerosis Society of America, and Crohn's & Colitis Foundation. The Foundation collaborates with regional hospitals such as Mount Sinai Hospital, Royal Free Hospital, Royal Victoria Hospital, Singapore General Hospital, and community clinics to disseminate treatment guidelines developed with contributions from experts affiliated with Mayo Clinic Proceedings, BMJ, Cochrane Collaboration, and the World Health Organization. Advocacy efforts have engaged policymakers at United States Congress, European Parliament, Health Canada, and national health ministries to improve access to therapies and orphan drug designations granted by agencies including FDA and European Medicines Agency.

Fundraising and Partnerships

Fundraising activities encompass donations, benefit events, and research auctions involving patrons connected to cultural institutions such as Metropolitan Museum of Art, Guggenheim Museum, Carnegie Hall, and sports partnerships with organizations like Major League Baseball, National Basketball Association, and United States Olympic & Paralympic Committee. Corporate partnerships include collaborations with pharmaceutical and biotech firms active in autoimmune therapeutics, venture philanthropies such as Accelerate Cure/Treatments for Autoimmune Diseases, and alliances with nonprofit funders including Robert Wood Johnson Foundation and Kresge Foundation. The Foundation has also engaged in collaborative consortia with registries like Orphanet, networks like European Reference Networks, and academic collaboratives modeled on All of Us Research Program.

Governance and Funding

Governance is overseen by a board with members drawn from institutions such as Harvard T.H. Chan School of Public Health, Princeton University, Stanford School of Medicine, Georgetown University, and Rice University. Scientific advisory committees include clinicians and investigators from University of Washington, NewYork-Presbyterian Hospital, Karolinska University Hospital, Sheffield Teaching Hospitals, and Royal Prince Alfred Hospital. Funding sources combine philanthropic contributions, charitable foundations, industry-sponsored grants, and income from educational programs; auditors and compliance advisors have included firms like Deloitte, Ernst & Young, and legal counsel with experience advising nonprofits such as Skadden, Arps, Slate, Meagher & Flom.

Impact and Recognition

The Foundation's impact is reflected in supported publications in journals including Nature, Science, Cell, The Lancet, JAMA, and New England Journal of Medicine and in awards to investigators who have received honors from Lasker Foundation, Royal Society, National Medal of Science, Gairdner Foundation, and Wilhelm Exner Medal. Its registries and sponsored trials contributed to clinical advances leading to guideline updates by American Academy of Dermatology and treatment approvals reviewed by Food and Drug Administration and European Medicines Agency. Recognition has come in the form of community awards from patient advocacy groups such as American Foundation for Suicide Prevention, collaborations acknowledged by World Health Organization, and citations in policy analyses from Institute of Medicine.

Category:Non-profit organizations based in Texas Category:Medical and health foundations